Guideline concordance in triple‐negative breast cancer: What does it measure?

Guideline‐concordant care in triple‐negative breast cancer was associated with improved survival, including from nonbreast cancer causes. This editorial explores what broader patient and health system influences, beyond treatment, are captured by guideline concordance.